RE:RE:Can't believe is under 10I think this stock got lot of people screwed up with that spike to 26 cents last year. people just thought its going to go higher and higher but it was definitely a spike only. shorters made lot of money and thats about it.
Since then management is also kind of silent and no positive news came out. We have few things that can happen in favor of the company like ICO-019 phase 2 start, IC0-008 licensing, any other drug candidate, clinical board hiring etc. But I think lesson to be learnt is that biopharma is not for every one. Its a patience game and for a long time your money can be stuck in a losing position. But this wont stay in this range forever. Outlook is positive but timing is not. So if you are in it for quick buck , then think of somewhere else. this aint the stock.